Bausch & Lomb Corp Business Combination, Contingent Consideration, Liability
Bausch & Lomb Corp (BLCO) had Business Combination, Contingent Consideration, Liability of $102.00 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2026-07-29
- 2026-06-30: Business Combination, Contingent Consideration, Liability $102.00M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability $98.00M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability $96.00M.
- 2024-12-31: Business Combination, Contingent Consideration, Liability $123.00M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2026-06-30 | $102.00M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $98.00M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $96.00M 10-Q · filed 2026-07-29 |
| 2024-12-31 | $123.00M 10-K · filed 2026-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |